29 results found.

Mild Cognitive Impairment Clinical Trial using [18F]NAV4694

Navidea Biopharmaceuticals - Recruiting 55 years or older.
- Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI).
[18F]NAV4694

Amnestic Mild Cognitive Impairment, or Alzheimer's Disease Clinical Trial using Insulin (Humulinr R U-100); Placebo

Alzheimer's Disease Cooperative Study (ADCS) - Recruiting 55 years to 85 years.
- Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD).
Insulin (Humulinr R U-100); Placebo

Amnestic Mild Cognitive Impairment, Alzheimer's Disease, or Prodr Clinical Trial using MK-8931; Placebo

Merck Sharp & Dohme Corp. - Recruiting 50 years to 85 years.
- A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD).
MK-8931; Placebo

Mild Cognitive Impairment, or Mild to Moderate Cognitive Impairme Clinical Trial using spectral-domain optical coherence tomography (SD-OCT)

Duke University - Recruiting 55 years or older.
- Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease.
spectral-domain optical coherence tomography (SD-OCT)

Mild Cognitive Impairment (MCI) Clinical Trial using Behavioral Activation (BA); Supportive Therapy (ST)

Thomas Jefferson University - Recruiting 65 years or older.
- Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment.
Behavioral Activation (BA); Supportive Therapy (ST)

Mild Cognitive Impairment Due to Alzheimer's Disease Clinical Trial using Pioglitazone; Pioglitazone placebo

Takeda - Recruiting 65 years to 83 years.
- A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment Due to Alzheimer's Disease (MCI Due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 0.8 SR mg QD) to Delay the Onset of MCI Due to AD in Cognitively Normal Subjects.
Pioglitazone; Pioglitazone placebo

Mild Cognitive Impairment Clinical Trial using External Counterpulsation (EECP)

University of Kansas - Recruiting 18 years to 85 years.
- Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients.
External Counterpulsation (EECP)

Parkinson's Disease, or Mild Cognitive Impairment Clinical Trial using Memory and Problem-Solving Intervention; Supportive Therapy

Virginia Commonwealth University - Recruiting 18 years or older.
- A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease.
Memory and Problem-Solving Intervention; Supportive Therapy

Mild Cognitive Impairment Clinical Trial

University of California, Los Angeles - Recruiting 60 years to 89 years.
- Physical Activity Levels and Hippocampal Sub-region Structure in MCI.

Vascular Mild Cognitive Impairment Clinical Trial using Attention Process Training-II

Azienda Ospedaliero-Universitaria Careggi - Recruiting 18 years or older.
- The Rehabilitation of Attention in Patients With Mild Cognitive Impairment and Brain Subcortical Vascular Changes Using the Attention Process Training-II.
Attention Process Training-II

Alzheimer Disease, Mild Cognitive Impairment, or Delirium, Dement Clinical Trial using Donepezil

New York State Psychiatric Institute - Recruiting 55 years to 95 years.
- Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly.
Donepezil

Mild Cognitive Impairment Clinical Trial using Donepezil; Atropine

New York State Psychiatric Institute - Recruiting 55 years to 95 years.
- Olfactory Deficits in Mild Cognitive Impairment as a Predictor of Improved Cognition on Donepezil.
Donepezil; Atropine

Mild Cognitive Impairment Clinical Trial using Atkins low carbohydrate diet; Healthy high carbohydrate diet

University of Cincinnati - Recruiting 60 years or older.
- Energy Metabolism and Cognitive Aging.
Atkins low carbohydrate diet; Healthy high carbohydrate diet

Alzheimer's Disease Clinical Trial using florbetapir F 18; 18F-AV-1451

Avid Radiopharmaceuticals - Recruiting 20 years or older.
- An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease.
florbetapir F 18; 18F-AV-1451

Mild Cognitive Impairment Clinical Trial using Medium Chain Triglyceride Oil; Placebo Oil

Pennington Biomedical Research Center - Recruiting 50 years or older.
- Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment.
Medium Chain Triglyceride Oil; Placebo Oil

Mild Cognitive Impairment Clinical Trial using Kundalini yoga and meditation; Memory Training

University of California, Los Angeles - Recruiting 55 years to 90 years.
- Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive Impairment.
Kundalini yoga and meditation; Memory Training

Mild Cognitive Impairment, So Stated Clinical Trial using Stimulation; SHAM

Charite University, Berlin, Germany - Recruiting 50 years to 80 years.
- Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Patients With Mild Cognitive Impairments(MCI).
Stimulation; SHAM

Mild Cognitive Impairment, Alzheimer's Disease, or Traumatic Brai Clinical Trial using explicit memory training; implicit memory training

Department of Veterans Affairs - Recruiting 18 years to 88 years.
- Behavioral and Neuroimaging Changes After Cognitive Rehab in TBI and MCI.
explicit memory training; implicit memory training

Mild Cognitive Impairment Clinical Trial using Transcranial direct current stimulation

The University of New South Wales - Recruiting 60 years to 85 years.
- .
Transcranial direct current stimulation

Mild Cognitive Impairment Clinical Trial using Simvastatin; Placebo

Charite University, Berlin, Germany - Recruiting 55 years to 90 years.
- Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients.
Simvastatin; Placebo

Mild Cognitive Impairment (MCI), or Alzheimer's Disease Clinical Trial

Alzheimer's Disease Cooperative Study (ADCS) - Recruiting 55 years to 90 years.
- Alzheimer's Disease Neuroimaging Initiative 2.

Mild Cognitive Impairment Clinical Trial using Omega-3 fatty acid supplementation

Clinica Universidad de Navarra, Universidad de Navarra - Recruiting 75 years or older.
- Field Trial With Omega-3 Fatty Acid Supplementation for the Prevention of Cognitive Decline in a Very Elderly Population.
Omega-3 fatty acid supplementation

Diabetes Mellitus, Type 2, Metabolic Syndrome X, or Mild Cognitiv Clinical Trial

Maastricht University Medical Center - Recruiting 40 years to 75 years.
- Functional MRI Biomarkers of Cognitive Decrements in Diabetes.

Falls, Gait, Balance, or Mild Cognitive Impairment (MCI) Clinical Trial using Donepezil

Lawson Health Research Institute - Recruiting 65 years or older.
- Can Cognitive Enhancers Reduce the Risk of Falls in Older People With Mild Cognitive Impairment? A Randomized Controled Trial.
Donepezil

Alzheimers Disease, or Mild Cognitive Impairment Clinical Trial

Roskilde County Hospital - Recruiting 50 years to 90 years.
- Quantitative Electroencephalography, Cerebrospinal Fluid Biomarkers, Linear CT Analyses and Timed Up and GO Dual Task as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression..

Mild Cognitive Impairment Clinical Trial using Grape Powder; Placebo Powder

University of California, Los Angeles - Recruiting 65 years or older.
- Examining the Impact of Grape Consumption on Brain Metabolism and Cognitive Function in Patients With Mild Cognitive Impairment.
Grape Powder; Placebo Powder

Mild Cognitive Impairment, or Cognitive Disorders Clinical Trial using 5-month aerobic exercise intervention

Wake Forest School of Medicine - Recruiting 60 years or older.
- Community-based, Buddy-supported Exercise in Patients With MCI: a Pilot Trial.
5-month aerobic exercise intervention

Alzheimer's Disease, Mild Cognitive Impairment, or Age-Related Me Clinical Trial

University of Arizona - Recruiting 50 years or older.
- Arizona Alzheimer's Disease Core Center.

Mild Cognitive Impairment (MCI) Clinical Trial using melatonin; placebo like melatonin tablets

Assaf-Harofeh Medical Center - Recruiting 55 years to 90 years.
- The Effect of Melatonin on Memory and Other Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment (MCI): A Placebo- Controlled Study..
melatonin; placebo like melatonin tablets